Therefore, after consideration of the public comment we received and our review of the device pass-through application, we are not approving the Axoguard HA+ Nerve Protector TM for transitional pass-through payment status for CY 2026 because the technology does not meet the substantial clinical improvement criterion at 419.66(c)(2)
The proliferative phase determines whether the ligament restores tensile strength or forms weak scar tissue prone to re-injury
FAK-paxillin signaling and F-actin cytoskeletal organization Molecular Modulation of the NO-system, VEGFR2 signaling, growth-hormone receptor expression in fibroblasts, and interactions with dopamine- and serotonin-related neurotransmitter pathways Systemic (Preclinical) Rodent models of gastrointestinal mucosal lesions, liver injury, tendon and ligament transection, and vascular occlusion syndromes References (BPC-157): Sikiric P, et al
In preliminary experiments, cyanide was first used in amounts (250 L of 1% NaCN solution (w/v)) equivalent to a literature value [14] for light-protected extractions in amber vials following the same procedures of the native SIDA method [7]
